PVT1 and colorectal cancer: PVT1 was found upregulated using quantitative RT-PCR in colorectal cancer patients refractory to 5-fluorouracil (5-FU) in neoadyuvancy (primary resistance), and also in colorectal and gastric cancer patients receiving but not benefiting from cisplatin (70, 108, 157).